Weigao was founded in 1988. With the simple and kindness of improving the lives of the elderly and widowed, he set up a small workshop in the township welfare home. Currently committed to developing its main business medical devices and medicine, covering an area of more than 6 million square meters, it has 13 industrial groups and more than 100 subsidiaries, including 3 listed companies and 8 overseas companies, and is located in 10 provinces and cities in China. A manufacturing base is built with more than 30,000 employees. We have always taken improving national health and breaking foreign monopoly as our mission. We have now become a global supplier of comprehensive, safe, reliable and trustworthy overall solutions for medical systems. Create a systematic R&D platform to enhance core competitiveness through innovation and enrich product structure. 15 national and provincial innovation platforms have been built, including the National Certified Enterprise Technology Center, National Engineering Research Center, National Innovation Pilot Enterprise, Academician Workstation, Postdoctoral Workstation, Taishan Scholar Laboratory, etc., and many other institutions, including the Chinese Academy of Sciences, the Chinese Academy of Engineering, 301 Hospital, etc. Our unit has carried out industry-university-research cooperation and established cooperative relationships with more than 100 academicians. It has more than 1,700 patents, more than 1,000 medical devices and drugs, and more than 200,000 specifications. Committed to solving the "bottleneck" problem in foreign countries, overcome 21 technical barriers, achieve domestic substitution for more than 100 products, undertake more than 30 national key projects, win 4 national scientific and technological progress awards, 2 national technological invention awards, and national excellent industry 1 gold medal in design. Adhere to scientific management and improve the management system. It has a national technical standard innovation base and a national certification and testing center, and has 1 international standards formulated by enterprises in the industry and 2 international standards proposals, leading or participating in 11 national standards. Improve product quality with advanced manufacturing technology, introduce advanced domestic and foreign automated production equipment, establish management systems such as intelligent manufacturing (MES), AI visual inspection, quality BI data, etc., continuously improve management and control processes, and carry out digital transformation to continuously improve production and manufacturing capabilities and Management level. Improve industrial layout, lay out chains, strengthen chains, and extend chains. Establish an industrial layout of the coordinated development of three types of business formats to create a medical ecological chain. The medical industry has focused on creating product lines such as clinical nursing, orthopedics, blood purification, drug packaging, medical intervention, surgical robots, and medical engineering. It ranks among the top in the country in terms of product lines such as nursing, hemodialysis, pharmaceutical packaging materials, and blood technology. The sales network is spread all over the country and abroad, with more than 100 sales offices, and has created the "Jierui" and "Vigao" brands, and its products are sold to more than 100 countries or regions around the world.
Weigao Group Co., Ltd.
Weigao was founded in 1988. With the simple and kindness of improving the lives of the elderly and widowed, he set up a small workshop in the township welfare home. Currently committed to developing its main business medical devices and medicine, covering an area of more than 6 million square meters, it has 13 industrial groups and more than 100 subsidiaries, including 3 listed companies and 8 overseas companies, and is located in 10 provinces and cities in China. A manufacturing base is built with more than 30,000 employees. We have always taken improving national health and breaking foreign monopoly as our mission. We have now become a global supplier of comprehensive, safe, reliable and trustworthy overall solutions for medical systems. Create a systematic R&D platform to enhance core competitiveness through innovation and enrich product structure. 15 national and provincial innovation platforms have been built, including the National Certified Enterprise Technology Center, National Engineering Research Center, National Innovation Pilot Enterprise, Academician Workstation, Postdoctoral Workstation, Taishan Scholar Laboratory, etc., and many other institutions, including the Chinese Academy of Sciences, the Chinese Academy of Engineering, 301 Hospital, etc. Our unit has carried out industry-university-research cooperation and established cooperative relationships with more than 100 academicians. It has more than 1,700 patents, more than 1,000 medical devices and drugs, and more than 200,000 specifications. Committed to solving the "bottleneck" problem in foreign countries, overcome 21 technical barriers, achieve domestic substitution for more than 100 products, undertake more than 30 national key projects, win 4 national scientific and technological progress awards, 2 national technological invention awards, and national excellent industry 1 gold medal in design. Adhere to scientific management and improve the management system. It has a national technical standard innovation base and a national certification and testing center, and has 1 international standards formulated by enterprises in the industry and 2 international standards proposals, leading or participating in 11 national standards. Improve product quality with advanced manufacturing technology, introduce advanced domestic and foreign automated production equipment, establish management systems such as intelligent manufacturing (MES), AI visual inspection, quality BI data, etc., continuously improve management and control processes, and carry out digital transformation to continuously improve production and manufacturing capabilities and Management level. Improve industrial layout, lay out chains, strengthen chains, and extend chains. Establish an industrial layout of the coordinated development of three types of business formats to create a medical ecological chain. The medical industry has focused on creating product lines such as clinical nursing, orthopedics, blood purification, drug packaging, medical intervention, surgical robots, and medical engineering. It ranks among the top in the country in terms of product lines such as nursing, hemodialysis, pharmaceutical packaging materials, and blood technology. The sales network is spread all over the country and abroad, with more than 100 sales offices, and has created the "Jierui" and "Vigao" brands, and its products are sold to more than 100 countries or regions around the world.
Chengdu Rich Science Industry Co., Ltd.
Headquartered in Chengdu hi-tech district, Chengdu Rich Science Industry Co., Ltd. is a hi-tech company with advanced research and development capability and first-class management.
We are devoting ourselves to research, production and marketing of hi-tech medical, biological medical devices. Our main products are Vacuum Blood Collection System, body juice specimen collection system, bacteria culture/verification system, bio-informational products, instruments and medical reagents which are used extensively in the fields of pharmacology, test, teaching and science research.We have obtained ISO9001:2000, ISO13485:2003 certificate and CE approval in 2005.
Based on our ontinuous principle of "C.D.RICH technology for society", we would like to make good cooperation with you.
Chengdu Rich Science Industry Co., Ltd.
Headquartered in Chengdu hi-tech district, Chengdu Rich Science Industry Co., Ltd. is a hi-tech company with advanced research and development capability and first-class management.
We are devoting ourselves to research, production and marketing of hi-tech medical, biological medical devices. Our main products are Vacuum Blood Collection System, body juice specimen collection system, bacteria culture/verification system, bio-informational products, instruments and medical reagents which are used extensively in the fields of pharmacology, test, teaching and science research.We have obtained ISO9001:2000, ISO13485:2003 certificate and CE approval in 2005.
Based on our ontinuous principle of "C.D.RICH technology for society", we would like to make good cooperation with you.
NINGBO YINGMED MEDICAL INSTRUMENTS CO.,LTD
Ningbo Yingmed Medical Instruments Co., Ltd is one of the professional supplier for the Medical Instuments products in China. Our Team has more than 15 years experiences in Medical field.
We export our products to customers in Europen, South Africa, South east of Asia, South America, Middle East. We are facroty , located in Jiangsu province, which is near Shanghai port, we produce Oxygen mask, Nebulizer mask, ET tubes, Latex Foley catheter, Tracheostomy tube, Syringe, and etc.
In order to fufill and increasing needs of our trusted and loyal customers, apart from our factory, we have more than 5 strategic partners which produce urine bags, surgical gowns, medical tubes, wound dressing, syringes, diagnostics & lab products.
We care the success of our customers, we know that the important of quality, so we set up a strong QC team stay in differences production lines to ensure & control quality.
Our Company is approved by CE&ISO certificates for most of products.
In future, Yingmed Medical will keep high efficient and professional for every cutomer, and associate company development with human health. We will do our best to put love and respect into our every product, and pass smile to everyone at the world.
NINGBO YINGMED MEDICAL INSTRUMENTS CO.,LTD
Ningbo Yingmed Medical Instruments Co., Ltd is one of the professional supplier for the Medical Instuments products in China. Our Team has more than 15 years experiences in Medical field.
We export our products to customers in Europen, South Africa, South east of Asia, South America, Middle East. We are facroty , located in Jiangsu province, which is near Shanghai port, we produce Oxygen mask, Nebulizer mask, ET tubes, Latex Foley catheter, Tracheostomy tube, Syringe, and etc.
In order to fufill and increasing needs of our trusted and loyal customers, apart from our factory, we have more than 5 strategic partners which produce urine bags, surgical gowns, medical tubes, wound dressing, syringes, diagnostics & lab products.
We care the success of our customers, we know that the important of quality, so we set up a strong QC team stay in differences production lines to ensure & control quality.
Our Company is approved by CE&ISO certificates for most of products.
In future, Yingmed Medical will keep high efficient and professional for every cutomer, and associate company development with human health. We will do our best to put love and respect into our every product, and pass smile to everyone at the world.
Jimin Healthcare Management Co., Ltd.
Jimin Health Management Co., Ltd. (hereinafter referred to as the "Company") is a modern pharmaceutical enterprise founded in 1996. It is a key backbone enterprise in the pharmaceutical industry in Zhejiang Province and a national high-tech enterprise. The company was launched on the Shanghai Stock Exchange in February 2015. Listed (603222.SH). The company is located in the Zhejiang Huangyan High-tech Development Park, covering an area of nearly 400 acres and has a total number of employees reaching more than 2,000. Since its listing, the company has actively deployed its "big health strategy". It covers three major sectors: medical and health services, medical devices and chemical and pharmaceuticals, and has initially built a strategic pattern of "one main and two wings" dominated by medical devices and coordinated development of medical services and chemical and pharmaceuticals. Medical devices are the core business segment of Jimin Health. The products include safe injection puncture device series, pre-charge catheter flusher series, in vitro diagnostic series and hemodialysis concentrate series. Among them, safe injection puncture device series products are internationally , and both are in the leading position in China. The company has been engaged in the injection and puncture device business for more than 30 years and is a leading enterprise in the domestic safety syringe segment. Its main products include safety syringes, safety injection needles, sterile syringes, infusion devices and other products. The company's new product, pre-filled catheter irrigator, is a clinical application product combining medicine and equipment. This product is mainly used in the maintenance of vascular access devices such as PICC (central venous catheterization through peripheral venous ventricular puncture), venous indwelling needles. Its operation is simple and has a wide range of applications, can reduce the consumption of multiple materials, reduce hospital infection risks, reduce needle stab injuries, avoid medication errors, improve safety, improve work flow and efficiency, etc., and has gradually become a traditional saline and heparin dilution solution. Excellent alternative to flushing tube liquid. The company's hemodialysis concentrate series products adopt ultrapure water production process that far exceeds the technical indicators of dialysis water, C+A cleanliness production environment, and automated production equipment to effectively ensure product quality. The company's wholly-owned subsidiary, Spain LINEAR, has seven major product lines including a variety of diagnostic reagents, laboratory instruments and in vitro diagnostic medical products. Its core products, FOB fecal occult blood automatic immune monitoring and Helicobacter pylori detection kit, have a strong market. Competitiveness. There are 2 comprehensive hospitals in the medical and health service sector (Boao International Hospital and Ezhou Second Hospital), and they have cooperated with many hospitals in hemodialysis business. In the future, the company will continue to plan comprehensive and specialized (oncology, kidney disease, etc.) hospitals, and is committed to building the company into a big health industry group. There are nearly 40 infusion varieties in the chemical pharmaceutical sector, and they have various products such as balance, nutrition, therapeutic infusion and external irrigation agents. Currently, the company has three major production bases in Zhejiang, Shanghai and Spain, and has 6 wholly-owned or controlled subsidiaries: Hainan Jimin Boao International Hospital Co., Ltd., Ezhou Second Hospital Co., Ltd., Renia Chemical Co., Ltd., Jumin Biology Technology Co., Ltd., Zhejiang Jimintang Pharmaceutical Trading Co., Ltd., Taizhou Jurui Plastic Technology Co., Ltd.
Jimin Healthcare Management Co., Ltd.
Jimin Health Management Co., Ltd. (hereinafter referred to as the "Company") is a modern pharmaceutical enterprise founded in 1996. It is a key backbone enterprise in the pharmaceutical industry in Zhejiang Province and a national high-tech enterprise. The company was launched on the Shanghai Stock Exchange in February 2015. Listed (603222.SH). The company is located in the Zhejiang Huangyan High-tech Development Park, covering an area of nearly 400 acres and has a total number of employees reaching more than 2,000. Since its listing, the company has actively deployed its "big health strategy". It covers three major sectors: medical and health services, medical devices and chemical and pharmaceuticals, and has initially built a strategic pattern of "one main and two wings" dominated by medical devices and coordinated development of medical services and chemical and pharmaceuticals. Medical devices are the core business segment of Jimin Health. The products include safe injection puncture device series, pre-charge catheter flusher series, in vitro diagnostic series and hemodialysis concentrate series. Among them, safe injection puncture device series products are internationally , and both are in the leading position in China. The company has been engaged in the injection and puncture device business for more than 30 years and is a leading enterprise in the domestic safety syringe segment. Its main products include safety syringes, safety injection needles, sterile syringes, infusion devices and other products. The company's new product, pre-filled catheter irrigator, is a clinical application product combining medicine and equipment. This product is mainly used in the maintenance of vascular access devices such as PICC (central venous catheterization through peripheral venous ventricular puncture), venous indwelling needles. Its operation is simple and has a wide range of applications, can reduce the consumption of multiple materials, reduce hospital infection risks, reduce needle stab injuries, avoid medication errors, improve safety, improve work flow and efficiency, etc., and has gradually become a traditional saline and heparin dilution solution. Excellent alternative to flushing tube liquid. The company's hemodialysis concentrate series products adopt ultrapure water production process that far exceeds the technical indicators of dialysis water, C+A cleanliness production environment, and automated production equipment to effectively ensure product quality. The company's wholly-owned subsidiary, Spain LINEAR, has seven major product lines including a variety of diagnostic reagents, laboratory instruments and in vitro diagnostic medical products. Its core products, FOB fecal occult blood automatic immune monitoring and Helicobacter pylori detection kit, have a strong market. Competitiveness. There are 2 comprehensive hospitals in the medical and health service sector (Boao International Hospital and Ezhou Second Hospital), and they have cooperated with many hospitals in hemodialysis business. In the future, the company will continue to plan comprehensive and specialized (oncology, kidney disease, etc.) hospitals, and is committed to building the company into a big health industry group. There are nearly 40 infusion varieties in the chemical pharmaceutical sector, and they have various products such as balance, nutrition, therapeutic infusion and external irrigation agents. Currently, the company has three major production bases in Zhejiang, Shanghai and Spain, and has 6 wholly-owned or controlled subsidiaries: Hainan Jimin Boao International Hospital Co., Ltd., Ezhou Second Hospital Co., Ltd., Renia Chemical Co., Ltd., Jumin Biology Technology Co., Ltd., Zhejiang Jimintang Pharmaceutical Trading Co., Ltd., Taizhou Jurui Plastic Technology Co., Ltd.
Berlang Medical (Shanghai) International Trade Co., Ltd.
The Berlan Group was founded in 1839 in the Meltsonggen region of Germany, with more than 66,000 employees in 64 countries around the world. After nearly two centuries of ups and downs and silent inheritance by several generations, Berlan has become the world's advanced medical equipment, medical products and services provider today, committed to infusion, anesthesia, dialysis, neurosurgery, spinal surgery, Provide solutions in related treatment areas such as diabetes care, clinical nutrition, wound management, infection prevention, etc. By having constructive dialogue with customers and partners, Berlan continuously develops high-quality innovative products and services for the healthcare system, thereby protecting and improving the health of human beings around the world. In 1985, Berlan established a branch in Hong Kong, China and officially launched its business in Greater China. After more than 30 years of development, Berlan has seven independent legal entities in China, headquartered in Shanghai, with branches in major Chinese cities such as Beijing, Guangzhou, and Wuhan. Its business covers more than 70 cities across the country and is in Jiangsu. Suzhou and Zibo, Shandong have invested in the construction of large production bases.
Berlang Medical (Shanghai) International Trade Co., Ltd.
The Berlan Group was founded in 1839 in the Meltsonggen region of Germany, with more than 66,000 employees in 64 countries around the world. After nearly two centuries of ups and downs and silent inheritance by several generations, Berlan has become the world's advanced medical equipment, medical products and services provider today, committed to infusion, anesthesia, dialysis, neurosurgery, spinal surgery, Provide solutions in related treatment areas such as diabetes care, clinical nutrition, wound management, infection prevention, etc. By having constructive dialogue with customers and partners, Berlan continuously develops high-quality innovative products and services for the healthcare system, thereby protecting and improving the health of human beings around the world. In 1985, Berlan established a branch in Hong Kong, China and officially launched its business in Greater China. After more than 30 years of development, Berlan has seven independent legal entities in China, headquartered in Shanghai, with branches in major Chinese cities such as Beijing, Guangzhou, and Wuhan. Its business covers more than 70 cities across the country and is in Jiangsu. Suzhou and Zibo, Shandong have invested in the construction of large production bases.
Jiangxi Yikang Medical Devices Group Co., Ltd.
Jiangxi Yikang Medical Equipment Group Co., Ltd. is located at No. 188, Lidu Aihua Avenue, Jinxian County, Nanchang City. It was founded in 1989. It is a large enterprise specializing in the production of disposable sterile medical equipment series products. The company has more than 2,000 employees, covering an area of more than 400 mu and a building area of more than 180,000 square meters. Among them, there are more than 48,000 square meters of purification workshops that meet the requirements of medical device production quality management specifications (GMP) standards, and more than 8,000 square meters have been built. , a scientific research building integrating R&D, testing and office. After nearly 30 years of continuous efforts, the company has developed into a group company integrating medical device production, education, research, sales and third-party logistics platforms, with 8 subsidiaries, from a single infusion product to the existing urinary urethrology. 7 major categories, including more than 50 varieties and more than 1,000 specifications of sterile medical device products, including more than 50 varieties and more than 1,000 specifications. The company has passed ISO13485 and EU CE certification, and passed the US FDA factory certification. The company has its own R&D center, and has developed more than 60 patented products with independent intellectual property rights. The products are sold to more than 30 provinces, cities, and autonomous regions across the country, and are exported to more than 30 countries and regions including Europe and the United States.
Jiangxi Yikang Medical Devices Group Co., Ltd.
Jiangxi Yikang Medical Equipment Group Co., Ltd. is located at No. 188, Lidu Aihua Avenue, Jinxian County, Nanchang City. It was founded in 1989. It is a large enterprise specializing in the production of disposable sterile medical equipment series products. The company has more than 2,000 employees, covering an area of more than 400 mu and a building area of more than 180,000 square meters. Among them, there are more than 48,000 square meters of purification workshops that meet the requirements of medical device production quality management specifications (GMP) standards, and more than 8,000 square meters have been built. , a scientific research building integrating R&D, testing and office. After nearly 30 years of continuous efforts, the company has developed into a group company integrating medical device production, education, research, sales and third-party logistics platforms, with 8 subsidiaries, from a single infusion product to the existing urinary urethrology. 7 major categories, including more than 50 varieties and more than 1,000 specifications of sterile medical device products, including more than 50 varieties and more than 1,000 specifications. The company has passed ISO13485 and EU CE certification, and passed the US FDA factory certification. The company has its own R&D center, and has developed more than 60 patented products with independent intellectual property rights. The products are sold to more than 30 provinces, cities, and autonomous regions across the country, and are exported to more than 30 countries and regions including Europe and the United States.
Jiangxi Sanxin Medical Technology Co., Ltd.
Jiangxi Sanxin Medical Technology Co., Ltd. (hereinafter referred to as Sanxin Medical, stock code: 300453) was founded in Sanjiang Town, Nanchang County in 1997. In 2003, it settled in Xiaolan Economic and Technological Development Zone. It is specialized in the research and development, manufacturing and sales of medical devices. The national high-tech enterprise that serves is a company listed on the A-share market in Jiangxi Province. As the leading unit of the Jiangxi Province High-performance Medical Device Industry Science and Technology Innovation Consortium, it guides the high-quality development of the Jiangxi Province medical device industry with practical actions and research results. The company is also an important member of multiple standardization technical committees such as national medical external circulation equipment, national medical syringes (needles), national infusion devices, etc., presided over and participated in the drafting of 15 national standards and industry standards.
Jiangxi Sanxin Medical Technology Co., Ltd.
Jiangxi Sanxin Medical Technology Co., Ltd. (hereinafter referred to as Sanxin Medical, stock code: 300453) was founded in Sanjiang Town, Nanchang County in 1997. In 2003, it settled in Xiaolan Economic and Technological Development Zone. It is specialized in the research and development, manufacturing and sales of medical devices. The national high-tech enterprise that serves is a company listed on the A-share market in Jiangxi Province. As the leading unit of the Jiangxi Province High-performance Medical Device Industry Science and Technology Innovation Consortium, it guides the high-quality development of the Jiangxi Province medical device industry with practical actions and research results. The company is also an important member of multiple standardization technical committees such as national medical external circulation equipment, national medical syringes (needles), national infusion devices, etc., presided over and participated in the drafting of 15 national standards and industry standards.
Shengang Medical Products Co., Ltd.
Shengguang Medical Products Co., Ltd. is a professional comprehensive production enterprise in the field of medical devices. It was founded in 1993 and achieved rapid large-scale development after its acquisition and restructuring in 2000. Over the past 28 years, the company has been based in the industries of medical devices, medical consumables, rehabilitation devices, health care devices, etc., and has always focused on the field of treatment and rehabilitation, constantly scientific practice, innovative development, improve the industrial chain, and meticulously cultivate product quality. The company adheres to the core concept of "making human beings healthier and wishing a better life", and provides medical products and medical services integrating treatment and rehabilitation for patients around the world, so that the overall strength of the company continues to increase, and the corporate culture and brand influence are deeply rooted in the hearts of the people. The company has rich experience in research and development, manufacturing, experimental inspection and quality control of disposable medical devices. There are 398 engineering and technical personnel in the R&D team, including 128 middle and senior technicians and 4 foreign experts. The company mainly produces 233 product series products including disposable infusion devices, disposable syringes, disposable intravenous needles, disposable precision filtration infusion devices, sanitary materials, anesthesia and other products. The company's products have passed the EU CE certification and ISO9001 and ISO13485 international quality management system certification, and meet the national CMD quality inspection standards. Products are sold well in more than 30 provinces and cities, and are exported to 81 countries and regions including the United Kingdom, the United States, Germany and Southeast Asia. They have established well-known foreign companies such as Baxter, Bidi, Germany Berlan and Japan Mishawa Co., Ltd. Product cooperation relationship enjoys a good reputation at home and abroad. The company is forward-looking and creatively designed to create a new product research and development system that combines industry, education, research and technology, and integrates science, industry and trade. It adheres to the principle of science, technology as the leader and innovation as the soul, and has successively cooperated with Beijing University of Chemical Technology, Jinan University and other countries' "211 Projects" We have cooperated with the "985 Innovation Platform" universities in advantageous areas and invested in the establishment of scientific research institutions such as the "Joint R&D Center for Application of Medical Polymer Materials" and the "Joint R&D Center for Life Science and Technology". Up to now, the company has obtained 52 patents, obtained one of the provincial major science and technology projects, and has been approved by the Henan Provincial Department of Science and Technology as the "Henan Province Minimally Invasive Intervention and Infusion Medical Device Engineering Technology Research Center". At the same time, the company is applying for a national enterprise technology center. Looking back on the past, we have a lot of results, and looking forward to the future, we have a long way to go. On the road to promoting the healthy development of enterprises and benefiting mankind, the Holy Light will continue to be enterprising and make great strides.
Shengang Medical Products Co., Ltd.
Shengguang Medical Products Co., Ltd. is a professional comprehensive production enterprise in the field of medical devices. It was founded in 1993 and achieved rapid large-scale development after its acquisition and restructuring in 2000. Over the past 28 years, the company has been based in the industries of medical devices, medical consumables, rehabilitation devices, health care devices, etc., and has always focused on the field of treatment and rehabilitation, constantly scientific practice, innovative development, improve the industrial chain, and meticulously cultivate product quality. The company adheres to the core concept of "making human beings healthier and wishing a better life", and provides medical products and medical services integrating treatment and rehabilitation for patients around the world, so that the overall strength of the company continues to increase, and the corporate culture and brand influence are deeply rooted in the hearts of the people. The company has rich experience in research and development, manufacturing, experimental inspection and quality control of disposable medical devices. There are 398 engineering and technical personnel in the R&D team, including 128 middle and senior technicians and 4 foreign experts. The company mainly produces 233 product series products including disposable infusion devices, disposable syringes, disposable intravenous needles, disposable precision filtration infusion devices, sanitary materials, anesthesia and other products. The company's products have passed the EU CE certification and ISO9001 and ISO13485 international quality management system certification, and meet the national CMD quality inspection standards. Products are sold well in more than 30 provinces and cities, and are exported to 81 countries and regions including the United Kingdom, the United States, Germany and Southeast Asia. They have established well-known foreign companies such as Baxter, Bidi, Germany Berlan and Japan Mishawa Co., Ltd. Product cooperation relationship enjoys a good reputation at home and abroad. The company is forward-looking and creatively designed to create a new product research and development system that combines industry, education, research and technology, and integrates science, industry and trade. It adheres to the principle of science, technology as the leader and innovation as the soul, and has successively cooperated with Beijing University of Chemical Technology, Jinan University and other countries' "211 Projects" We have cooperated with the "985 Innovation Platform" universities in advantageous areas and invested in the establishment of scientific research institutions such as the "Joint R&D Center for Application of Medical Polymer Materials" and the "Joint R&D Center for Life Science and Technology". Up to now, the company has obtained 52 patents, obtained one of the provincial major science and technology projects, and has been approved by the Henan Provincial Department of Science and Technology as the "Henan Province Minimally Invasive Intervention and Infusion Medical Device Engineering Technology Research Center". At the same time, the company is applying for a national enterprise technology center. Looking back on the past, we have a lot of results, and looking forward to the future, we have a long way to go. On the road to promoting the healthy development of enterprises and benefiting mankind, the Holy Light will continue to be enterprising and make great strides.
Wuxi Gukang Medical Equipment Co., Ltd.
Wuxi GUKANG Medical Equipment Co.,Ltd is set up in 2000,located in Wuxi Jiangyin where about 2 hours' drive from Shanghai.We have witnessed the vigorous development of the medical device industry,and have also been continuously optimizing its own infrastructure equipment and personnel as the industry becomes more standardize.Usually we have customized services for each customer in order to provide the heroes on the frontlines of healthcare with safer and more convenient products.Stable quality and Patient service have helped us accumulate a lot of customer resources,from which we have also gained rich experience so that we can provide customers with professional and diversified solutions in the future.
Wuxi Gukang Medical Equipment Co., Ltd.
Wuxi GUKANG Medical Equipment Co.,Ltd is set up in 2000,located in Wuxi Jiangyin where about 2 hours' drive from Shanghai.We have witnessed the vigorous development of the medical device industry,and have also been continuously optimizing its own infrastructure equipment and personnel as the industry becomes more standardize.Usually we have customized services for each customer in order to provide the heroes on the frontlines of healthcare with safer and more convenient products.Stable quality and Patient service have helped us accumulate a lot of customer resources,from which we have also gained rich experience so that we can provide customers with professional and diversified solutions in the future.
Anhui Hongyu Wuzhou Medical Devices Co., Ltd.
Anhui Hongyu Wuzhou Medical Equipment Co., Ltd. Located at No. 2 Guanyin Road, Taihu Economic Development Zone, Anhui Province. Located in the southwestern border of Anhui Province and the southern edge of Dabie Mountains, it has a superior geographical location and an elegant environment. 245 kilometers from the provincial capital Hefei City, 125 kilometers from the land route of Anqing City, close to the entrance of the Shanghai-Chengdu Expressway, 2 kilometers from the Taihu Station of Hejiu Railway, National Highway 105 Bus Station, and only needs to be opened to the water transport port Anqing Port and the airline Anqing Airport It takes 1 hour to drive, within 2 hours to the provincial capital Hefei, Hubei Wuhan, and Nanchang, Jiangxi. Expressways and railways are crisscrossing the territory, and the traffic is fast. The company invested 250 million yuan in the first phase, covering an area of 138 mu, with a construction area of 38,000 square meters. It has a 100,000-square-meter purification workshop that meets GMP standards and advanced automated production equipment at home and abroad, and has established various performances in line with the product. physical and chemical testing and testing center. The company's products are mainly: disposable sterile syringes, disposable infusion devices, disposable buret infusion devices, disposable bag-type infusion devices, disposable blood transfusion devices, disposable sterile injection needles, and a single Use infusion needles, etc. The company is based on the business philosophy of pursuing excellent quality and caring for human health, adhering to the quality policy of striving to be the first-class in China in science and technology, creating high-quality products, meeting the requirements of laws and regulations, serving customers satisfactorily, and repaying society. Bringing professional management talents in the industry, establishing and improving a modern enterprise management system, establishing a quality assurance system in accordance with the requirements of ISO9001, IS13485 and medical device production quality management standards, running through the entire production process, producing zero-defect products, and always being responsible for users' trust manufacturer.
Anhui Hongyu Wuzhou Medical Devices Co., Ltd.
Anhui Hongyu Wuzhou Medical Equipment Co., Ltd. Located at No. 2 Guanyin Road, Taihu Economic Development Zone, Anhui Province. Located in the southwestern border of Anhui Province and the southern edge of Dabie Mountains, it has a superior geographical location and an elegant environment. 245 kilometers from the provincial capital Hefei City, 125 kilometers from the land route of Anqing City, close to the entrance of the Shanghai-Chengdu Expressway, 2 kilometers from the Taihu Station of Hejiu Railway, National Highway 105 Bus Station, and only needs to be opened to the water transport port Anqing Port and the airline Anqing Airport It takes 1 hour to drive, within 2 hours to the provincial capital Hefei, Hubei Wuhan, and Nanchang, Jiangxi. Expressways and railways are crisscrossing the territory, and the traffic is fast. The company invested 250 million yuan in the first phase, covering an area of 138 mu, with a construction area of 38,000 square meters. It has a 100,000-square-meter purification workshop that meets GMP standards and advanced automated production equipment at home and abroad, and has established various performances in line with the product. physical and chemical testing and testing center. The company's products are mainly: disposable sterile syringes, disposable infusion devices, disposable buret infusion devices, disposable bag-type infusion devices, disposable blood transfusion devices, disposable sterile injection needles, and a single Use infusion needles, etc. The company is based on the business philosophy of pursuing excellent quality and caring for human health, adhering to the quality policy of striving to be the first-class in China in science and technology, creating high-quality products, meeting the requirements of laws and regulations, serving customers satisfactorily, and repaying society. Bringing professional management talents in the industry, establishing and improving a modern enterprise management system, establishing a quality assurance system in accordance with the requirements of ISO9001, IS13485 and medical device production quality management standards, running through the entire production process, producing zero-defect products, and always being responsible for users' trust manufacturer.
Terumo (China) Investment Co., Ltd.
Import channels were interrupted during World War I, and Japanese medical scientists made efforts to localize the thermometers as their goal. In 1921, medical scientists led by Dr. Shibasaburo Kitari founded the Telmao Company. Since its establishment, Termau has inherited the innovative challenge spirit of Dr. Beili, implemented the company philosophy of "contributing to society through medical care", and is committed to delivering excellent innovative technologies to the medical site. Telmao Co., Ltd. was founded in 1921. Its products include disposable medical devices, blood transfusion tools series, pharmaceutical and nutritional medicine series, angiography and therapeutic catheter, medical electronic products series, artificial heart and lung product series, etc. Termau's products have been widely used in many countries and regions around the world. Termau's unique technology will make the medical process humanized and gentle. The application of Telmao's new technology can relieve pain and discomfort during medical treatment as much as possible. Telmau has always been committed to developing medical products that meet high standards, not only meeting high standards in terms of safety and precision, but also in maintaining patients' good recovery and quality of life. At present, Telmao has established two factories in Hangzhou and Changchun, China respectively. Termau will dedicate mild, easy-to-use healthcare products and technologies to the world in the 21st century. In order to strengthen the integrated management of R&D, production and sales in China, Telmao applied for the establishment of Telmao (China) Investment Co., Ltd. in August 2012, with a registered capital of US$30 million. According to the early business strategy, the sales ratio of domestic products will be gradually increased in the future. The establishment of Telmao (China) Investment Co., Ltd. has also taken a big step to integrating the Greater China Circle Management Model in the Mainland, Hong Kong, Macau and Taiwan markets.
Terumo (China) Investment Co., Ltd.
Import channels were interrupted during World War I, and Japanese medical scientists made efforts to localize the thermometers as their goal. In 1921, medical scientists led by Dr. Shibasaburo Kitari founded the Telmao Company. Since its establishment, Termau has inherited the innovative challenge spirit of Dr. Beili, implemented the company philosophy of "contributing to society through medical care", and is committed to delivering excellent innovative technologies to the medical site. Telmao Co., Ltd. was founded in 1921. Its products include disposable medical devices, blood transfusion tools series, pharmaceutical and nutritional medicine series, angiography and therapeutic catheter, medical electronic products series, artificial heart and lung product series, etc. Termau's products have been widely used in many countries and regions around the world. Termau's unique technology will make the medical process humanized and gentle. The application of Telmao's new technology can relieve pain and discomfort during medical treatment as much as possible. Telmau has always been committed to developing medical products that meet high standards, not only meeting high standards in terms of safety and precision, but also in maintaining patients' good recovery and quality of life. At present, Telmao has established two factories in Hangzhou and Changchun, China respectively. Termau will dedicate mild, easy-to-use healthcare products and technologies to the world in the 21st century. In order to strengthen the integrated management of R&D, production and sales in China, Telmao applied for the establishment of Telmao (China) Investment Co., Ltd. in August 2012, with a registered capital of US$30 million. According to the early business strategy, the sales ratio of domestic products will be gradually increased in the future. The establishment of Telmao (China) Investment Co., Ltd. has also taken a big step to integrating the Greater China Circle Management Model in the Mainland, Hong Kong, Macau and Taiwan markets.
Beijing QuickSorb Medical Technology Co., Ltd.
Founded in 2007, Beijing Kuaishuer Medical Technology Co., Ltd. is a technology-based enterprise focusing on the research, development, production and sales of needleless syringes products in various fields. The company's production base and R&D center are located in Yizhuang Economic Development Zone, Daxing District, Beijing. It has a purification workshop of 100,000 and sterile laboratories of 10,000 levels, and adopts imported automated production lines from abroad. The annual production capacity of syringes is as high as one million units. Since the company launched its products, it has invested huge investment in new product research and development every year. The R&D team is composed of technical talents from domestic and foreign universities (75% are returned from studying in France, Denmark, Germany and the United States, and 25% graduated from Tsinghua, Beijing. The university, Beijing University of Aeronautics and Astronautics and other first-class domestic universities) are specialized in mechatronics, fluid mechanics, mold design, product industrial design, electronic application, biology, etc., and have applied for 23 domestic and foreign patents, including Germany, Japan, the United States, etc. As an industry model, Kushuer has always been a benchmark enterprise in needle-free injection and drug delivery systems, and has been leading the way in defining new standards for quality of needle-free injection systems. Currently, it has passed the 13485 and EU CE quality system certification of TÜV SÜD organization in Germany.
Beijing QuickSorb Medical Technology Co., Ltd.
Founded in 2007, Beijing Kuaishuer Medical Technology Co., Ltd. is a technology-based enterprise focusing on the research, development, production and sales of needleless syringes products in various fields. The company's production base and R&D center are located in Yizhuang Economic Development Zone, Daxing District, Beijing. It has a purification workshop of 100,000 and sterile laboratories of 10,000 levels, and adopts imported automated production lines from abroad. The annual production capacity of syringes is as high as one million units. Since the company launched its products, it has invested huge investment in new product research and development every year. The R&D team is composed of technical talents from domestic and foreign universities (75% are returned from studying in France, Denmark, Germany and the United States, and 25% graduated from Tsinghua, Beijing. The university, Beijing University of Aeronautics and Astronautics and other first-class domestic universities) are specialized in mechatronics, fluid mechanics, mold design, product industrial design, electronic application, biology, etc., and have applied for 23 domestic and foreign patents, including Germany, Japan, the United States, etc. As an industry model, Kushuer has always been a benchmark enterprise in needle-free injection and drug delivery systems, and has been leading the way in defining new standards for quality of needle-free injection systems. Currently, it has passed the 13485 and EU CE quality system certification of TÜV SÜD organization in Germany.
BD Medical Devices (Shanghai) Co., Ltd.
Bidi Medical is a global medical technology company that leads the world's health by improving medical discovery methods, medical diagnostic effects and care quality. Bidi Medical focuses and supports every front-line medical worker, and is committed to helping patients improve clinical treatment through the development of innovative technologies, services and solutions, and helping medical staff improve clinical processes. Beddy Medical and its 75,000 global employees uphold a high level of enthusiasm and belief to provide clinical medical staff with a safe and efficient nursing delivery process, assist laboratory scientists in diagnosing diseases more effectively, and enhance the research and development of a new generation of diagnosis and Ability to treat diseases. Bidi Medical has branches in almost all countries and actively cooperates with organizations around the world to work together to address challenging global health issues. Through close collaboration with customers, Bidi Medical takes it as its mission to improve treatment outcomes, reduce medical costs, and improve diagnostic efficiency, helping to strengthen the safety of patients and medical staff and expand medical access. In 1994, Bidi Medical officially sent personnel to register and establish a representative agency in China to carry out business with China. Currently, it has formed a regional headquarters with Shanghai, with offices in cities such as Beijing, Guangzhou, and Chengdu, with nearly 4,000 employees. In the past 30 years, Bidi Medical has adhered to the concept of "rooted in China, serving China" (In China, For China), and is committed to building high-quality local multinational medical technology companies, with a total investment of hundreds of millions of dollars and building three major local factories. 2 R&D centers and 1 customer service center, and a customer experience center, several professional training centers and laboratories, as well as the comprehensive Bidi Medical Greater China Innovation Center officially completed in 2023, actively practicing health care China 2030 will benefit more Chinese patients and medical workers and help promote the progress of medical industry.
BD Medical Devices (Shanghai) Co., Ltd.
Bidi Medical is a global medical technology company that leads the world's health by improving medical discovery methods, medical diagnostic effects and care quality. Bidi Medical focuses and supports every front-line medical worker, and is committed to helping patients improve clinical treatment through the development of innovative technologies, services and solutions, and helping medical staff improve clinical processes. Beddy Medical and its 75,000 global employees uphold a high level of enthusiasm and belief to provide clinical medical staff with a safe and efficient nursing delivery process, assist laboratory scientists in diagnosing diseases more effectively, and enhance the research and development of a new generation of diagnosis and Ability to treat diseases. Bidi Medical has branches in almost all countries and actively cooperates with organizations around the world to work together to address challenging global health issues. Through close collaboration with customers, Bidi Medical takes it as its mission to improve treatment outcomes, reduce medical costs, and improve diagnostic efficiency, helping to strengthen the safety of patients and medical staff and expand medical access. In 1994, Bidi Medical officially sent personnel to register and establish a representative agency in China to carry out business with China. Currently, it has formed a regional headquarters with Shanghai, with offices in cities such as Beijing, Guangzhou, and Chengdu, with nearly 4,000 employees. In the past 30 years, Bidi Medical has adhered to the concept of "rooted in China, serving China" (In China, For China), and is committed to building high-quality local multinational medical technology companies, with a total investment of hundreds of millions of dollars and building three major local factories. 2 R&D centers and 1 customer service center, and a customer experience center, several professional training centers and laboratories, as well as the comprehensive Bidi Medical Greater China Innovation Center officially completed in 2023, actively practicing health care China 2030 will benefit more Chinese patients and medical workers and help promote the progress of medical industry.
Shanghai Kindly Enterprise Development Group Co., Ltd.
Shanghai Condelay Enterprise Development Group Co., Ltd. (hereinafter referred to as: Condelay; stock code 603987), Condelay was founded in Wenzhou in 1987. Condelay's headquarters is located at No. 658, Gaochao Road, Jiangqiao Town, Jiading District, Shanghai, mainly engaged in medical puncture. The research and development, production and sales of devices are mainly medical puncture needles and medical puncture devices. The company is a cutting-edge enterprise in domestic medical puncture needle manufacturing technology and one of the few domestic manufacturers with a complete industrial chain of medical puncture devices. As the parent company of Condelay listed company, through capital operations and industrial operations, the company currently has more than 50 subsidiaries, all of which are medical puncture products production and operation and distribution enterprises. In terms of industry status, the company is not only responsible for/participated in the drafting of disposable infusion devices, blood transfusion devices, syringes, injection needles, intravenous infusion needles, medical stainless syringes, and six national standards, but also participated in the drafting of disposable anesthesia needles. , drafting of thirteen industry standards, including special needles for implantable drug delivery devices, biopsy needles, intravenous indwelling needles, sterile dental injection needles, dental cartridge syringes, and final sterilized medical device packaging materials. The company has established a complete medical device quality management system in accordance with national regulations based on the quality policy of "creating KDL brand and winning hundreds of millions of users". At the same time, a scientific research and development system that combines schools and enterprises has also been established, and has obtained more than 200 domestic and international patents. It has been successively recognized as a "high-tech enterprise", "patent demonstration enterprise", "municipal technology research and development center", and "Shanghai" The Municipal Science and Technology Little Giant Enterprise” has received support from Shanghai Torch Plan and Shanghai High-tech Achievements Transformation and other projects on many occasions. The products are sold to provinces, cities, autonomous regions, and municipalities in China, and are exported to more than 50 countries and regions including the United States, Europe, South America, the Middle East, Southeast Asia, etc., and have formed a stable cooperative relationship. "Sympathy, win-win, and common development" is Condelay's unchanging cultural concept. The company will continue to adhere to the positioning of high-quality products and technological innovation, provide high-quality products and services for human health, and work hand in hand with its domestic and foreign counterparts to further develop China's medical and health industry has made new contributions!
Shanghai Kindly Enterprise Development Group Co., Ltd.
Shanghai Condelay Enterprise Development Group Co., Ltd. (hereinafter referred to as: Condelay; stock code 603987), Condelay was founded in Wenzhou in 1987. Condelay's headquarters is located at No. 658, Gaochao Road, Jiangqiao Town, Jiading District, Shanghai, mainly engaged in medical puncture. The research and development, production and sales of devices are mainly medical puncture needles and medical puncture devices. The company is a cutting-edge enterprise in domestic medical puncture needle manufacturing technology and one of the few domestic manufacturers with a complete industrial chain of medical puncture devices. As the parent company of Condelay listed company, through capital operations and industrial operations, the company currently has more than 50 subsidiaries, all of which are medical puncture products production and operation and distribution enterprises. In terms of industry status, the company is not only responsible for/participated in the drafting of disposable infusion devices, blood transfusion devices, syringes, injection needles, intravenous infusion needles, medical stainless syringes, and six national standards, but also participated in the drafting of disposable anesthesia needles. , drafting of thirteen industry standards, including special needles for implantable drug delivery devices, biopsy needles, intravenous indwelling needles, sterile dental injection needles, dental cartridge syringes, and final sterilized medical device packaging materials. The company has established a complete medical device quality management system in accordance with national regulations based on the quality policy of "creating KDL brand and winning hundreds of millions of users". At the same time, a scientific research and development system that combines schools and enterprises has also been established, and has obtained more than 200 domestic and international patents. It has been successively recognized as a "high-tech enterprise", "patent demonstration enterprise", "municipal technology research and development center", and "Shanghai" The Municipal Science and Technology Little Giant Enterprise” has received support from Shanghai Torch Plan and Shanghai High-tech Achievements Transformation and other projects on many occasions. The products are sold to provinces, cities, autonomous regions, and municipalities in China, and are exported to more than 50 countries and regions including the United States, Europe, South America, the Middle East, Southeast Asia, etc., and have formed a stable cooperative relationship. "Sympathy, win-win, and common development" is Condelay's unchanging cultural concept. The company will continue to adhere to the positioning of high-quality products and technological innovation, provide high-quality products and services for human health, and work hand in hand with its domestic and foreign counterparts to further develop China's medical and health industry has made new contributions!
Chengdu Xinjin Shifeng Medical Devices Co., Ltd.
Chengdu Xinjin Shifeng Medical Equipment Co., Ltd. is a leading enterprise in the production of disposable sterile medical equipment series products in western China. The company was founded in 1991. The total assets are RMB 460 million, the number of employees is 1,100, and it has three major production plants: Xinping Production Base, Jinhua Smart Factory, and Pakistan Factory. The business involves the research, development, production and sales of disposable sterile medical device products of more than 100 varieties of disposable sterile medical device products in 53 categories, including disposable infusion devices, bag infusion devices, syringes, injection needles. Currently, there are more than 1,200 employees, 22,000 square meters of purification plant, 6 purification workshops, more than 80 production lines, more than 500 automated production equipment, products cover more than 4,800 hospitals, registered capital of 40.7868 million yuan, now It has nearly 500 million yuan in assets and achieved tax revenue of 57 million yuan in 2020. The company has three major production bases, the Baodun production base in Xinjin District, the Tianfu New District Intelligent Manufacturing Industrial Park production base, and the Lahore factory in Pakistan. Among them, the production base of the Tianfu New District Intelligent Manufacturing Industrial Park is the headquarters of the group. The base widely adopts advanced information technology of intelligent manufacturing, intelligent warehousing, and smart parks, and is based on creating a leading domestic industry benchmark smart factory. Since 1998, the company has gradually built a complete quality management system and a strict internal control system. The company has obtained ISO9001 and ISO13485 quality system certification since 2002. At present, the company has passed ISO9001, ISO13485 quality management system certification, 93/42/EEC EC Directive and U.S. Federal Regulations Code Volume 21, Part 820 (passed the FDA on-site inspection. ), WHO's PQS certification, China Medical Device Quality Management Standard GMP certification, ISO14001 Environmental Management System Certification, and major products have obtained EU CE certification and FDA product registration and filing registration. The company mainly engages in infusion/blood device (TPE, precision, bag type, light-proof, automatic liquid-resistance and other functional types); syringes, feeders, irrigators, extracorporeal blood circulation, arteriovenous puncture needles, indwelling needles, etc. Clinical nursing products; disposable sterile medical device products of more than 120 registered varieties of 54 major categories, including protective clothing, medical protective masks, surgical masks, sanitary dressings, sampling tubes, samplers and other epidemic prevention products series. The company implements group governance and strengthens international cooperation. Give full play to the spirit of craftsmanship, leverage talent advantages, base ourselves in the southwest and go to the world. We will give full play to the company's production and manufacturing advantages, and use the medical device registration and holder system to vigorously carry out OEM and ODM businesses, and strive to build Shifeng into a "world factory" for sterile medical devices. The company will take the four first-class development goals of the company: "creating first-class factories, cultivating first-class talents, manufacturing first-class products, and providing first-class compensation", and make greater contributions to the development and progress of disposable sterile medical devices and human health.
Chengdu Xinjin Shifeng Medical Devices Co., Ltd.
Chengdu Xinjin Shifeng Medical Equipment Co., Ltd. is a leading enterprise in the production of disposable sterile medical equipment series products in western China. The company was founded in 1991. The total assets are RMB 460 million, the number of employees is 1,100, and it has three major production plants: Xinping Production Base, Jinhua Smart Factory, and Pakistan Factory. The business involves the research, development, production and sales of disposable sterile medical device products of more than 100 varieties of disposable sterile medical device products in 53 categories, including disposable infusion devices, bag infusion devices, syringes, injection needles. Currently, there are more than 1,200 employees, 22,000 square meters of purification plant, 6 purification workshops, more than 80 production lines, more than 500 automated production equipment, products cover more than 4,800 hospitals, registered capital of 40.7868 million yuan, now It has nearly 500 million yuan in assets and achieved tax revenue of 57 million yuan in 2020. The company has three major production bases, the Baodun production base in Xinjin District, the Tianfu New District Intelligent Manufacturing Industrial Park production base, and the Lahore factory in Pakistan. Among them, the production base of the Tianfu New District Intelligent Manufacturing Industrial Park is the headquarters of the group. The base widely adopts advanced information technology of intelligent manufacturing, intelligent warehousing, and smart parks, and is based on creating a leading domestic industry benchmark smart factory. Since 1998, the company has gradually built a complete quality management system and a strict internal control system. The company has obtained ISO9001 and ISO13485 quality system certification since 2002. At present, the company has passed ISO9001, ISO13485 quality management system certification, 93/42/EEC EC Directive and U.S. Federal Regulations Code Volume 21, Part 820 (passed the FDA on-site inspection. ), WHO's PQS certification, China Medical Device Quality Management Standard GMP certification, ISO14001 Environmental Management System Certification, and major products have obtained EU CE certification and FDA product registration and filing registration. The company mainly engages in infusion/blood device (TPE, precision, bag type, light-proof, automatic liquid-resistance and other functional types); syringes, feeders, irrigators, extracorporeal blood circulation, arteriovenous puncture needles, indwelling needles, etc. Clinical nursing products; disposable sterile medical device products of more than 120 registered varieties of 54 major categories, including protective clothing, medical protective masks, surgical masks, sanitary dressings, sampling tubes, samplers and other epidemic prevention products series. The company implements group governance and strengthens international cooperation. Give full play to the spirit of craftsmanship, leverage talent advantages, base ourselves in the southwest and go to the world. We will give full play to the company's production and manufacturing advantages, and use the medical device registration and holder system to vigorously carry out OEM and ODM businesses, and strive to build Shifeng into a "world factory" for sterile medical devices. The company will take the four first-class development goals of the company: "creating first-class factories, cultivating first-class talents, manufacturing first-class products, and providing first-class compensation", and make greater contributions to the development and progress of disposable sterile medical devices and human health.
Cardinal Health is a global, integrated healthcare services and products company providing customized solutions for hospitals, pharmacies, and laboratories.
Cardinal Health, Inc.
Cardinal Health is a global, integrated healthcare services and products company providing customized solutions for hospitals, pharmacies, and laboratories.
Fresenius Kabi (China) Investment Co., Ltd.
Fresenius Cabi is a global enterprise focusing on the fields of infusion, blood transfusion and clinical nutrition. Fresenius Cabi provides reliable medical guarantees for patients with severe and chronic diseases with high-quality medicines, medical devices and services. Fresenius Cabi ’s product range includes intravenous medications, infusion therapy, clinical nutrition, and the medical devices required to apply these products. In the field of biosimilars, Fresenius Cabi focuses on autoimmune diseases and oncology. In terms of blood transfusion medicine and cell therapy devices, Fisseus Cabi provides blood component collection and in vitro cell therapy products. Taking care of life as its mission, Ferseniusca is committed to providing medical staff with essential medicines and technologies and helping them find quality solutions to solve problems. Since entering China, Fresenius Cabi has always regarded "caring for life" as the driving force for continuous development and progress, and is committed to helping the Chinese people improve their health and quality of life. Rooted in China for more than 30 years, Fresenius Cabi has been engaged in medicines, clinical nutrition, medical devices and other fields, thanks to its excellent products and technologies, standardized management, professional services, and efficient operation of R&D, production and marketing systems.业务领域取得骄人业绩，并发展成为中国临床营养、肾病营养治疗和麻醉治疗领域的领导者之一。
Fresenius Kabi (China) Investment Co., Ltd.
Fresenius Cabi is a global enterprise focusing on the fields of infusion, blood transfusion and clinical nutrition. Fresenius Cabi provides reliable medical guarantees for patients with severe and chronic diseases with high-quality medicines, medical devices and services. Fresenius Cabi ’s product range includes intravenous medications, infusion therapy, clinical nutrition, and the medical devices required to apply these products. In the field of biosimilars, Fresenius Cabi focuses on autoimmune diseases and oncology. In terms of blood transfusion medicine and cell therapy devices, Fisseus Cabi provides blood component collection and in vitro cell therapy products. Taking care of life as its mission, Ferseniusca is committed to providing medical staff with essential medicines and technologies and helping them find quality solutions to solve problems. Since entering China, Fresenius Cabi has always regarded "caring for life" as the driving force for continuous development and progress, and is committed to helping the Chinese people improve their health and quality of life. Rooted in China for more than 30 years, Fresenius Cabi has been engaged in medicines, clinical nutrition, medical devices and other fields, thanks to its excellent products and technologies, standardized management, professional services, and efficient operation of R&D, production and marketing systems.业务领域取得骄人业绩，并发展成为中国临床营养、肾病营养治疗和麻醉治疗领域的领导者之一。
Baxter (China) Investment Co., Ltd.
Baxter makes changes to the lives of millions of people around the world every day. The company's products and therapies are found in hospitals and clinics—from emergency rooms to operating rooms, from pharmacies to intensive care units—and improve patients' home treatment. For more than 80 years, I have always been at the important intersection of saving and continuing my life. Now, Baxter has the determination and ability to seize opportunities in the next few years to bring about change to global healthcare. Baxter came to China in the 1980s and is one of the largest multinational medical companies to enter the Chinese medical market earlier. Adhering to the corporate mission of "saving and continuing life", Baxter focuses on assisting in improving medical standards, expanding medical accessibility, and giving back to society, making meaningful contributions to the lives and quality of life of Chinese patients and helping China Sustainable development of medical care. Currently, Baxter has established 11 institutions and offices, 5 factories, 1 R&D center, and 1 technical service center in China.
Baxter (China) Investment Co., Ltd.
Baxter makes changes to the lives of millions of people around the world every day. The company's products and therapies are found in hospitals and clinics—from emergency rooms to operating rooms, from pharmacies to intensive care units—and improve patients' home treatment. For more than 80 years, I have always been at the important intersection of saving and continuing my life. Now, Baxter has the determination and ability to seize opportunities in the next few years to bring about change to global healthcare. Baxter came to China in the 1980s and is one of the largest multinational medical companies to enter the Chinese medical market earlier. Adhering to the corporate mission of "saving and continuing life", Baxter focuses on assisting in improving medical standards, expanding medical accessibility, and giving back to society, making meaningful contributions to the lives and quality of life of Chinese patients and helping China Sustainable development of medical care. Currently, Baxter has established 11 institutions and offices, 5 factories, 1 R&D center, and 1 technical service center in China.
Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
SCHOTT (Shanghai) Precision Materials and Equipment International Trade Co., Ltd.
Schott is an outstanding multinational high-tech group company in the fields of specialty glass and microcrystalline glass. Accumulated over 130 years of R&D, materials and technical expertise, and has a wide range of high-quality products and smart solutions. Short is an innovation driver in a wide range of industries, including the household appliances, medicine, electronics, optics, automotive and aviation industries. Short strives to play an important role in improving people’s quality of life and focuses on promoting innovation and sustainable development. Schott Group has production bases and sales companies in 35 countries around the world. SCHOTT AG, headquartered in Mainz, Germany, is a wholly owned by the Carl Zeiss Foundation. As a company affiliated with the Foundation, Short has special responsibilities to its employees, society as a whole, and the environment. The Short Group owns a number of companies in China, including the Short (Shanghai) Precision Materials and Equipment International Trading Co., Ltd., the Short Glass Technology (Suzhou) Co., Ltd., the Short China Co., Ltd. (Hong Kong) and the joint venture company, the Short Xin Kang Pharmaceutical Packaging Co., Ltd., etc., have a total of more than 800 employees.
SCHOTT (Shanghai) Precision Materials and Equipment International Trade Co., Ltd.
Schott is an outstanding multinational high-tech group company in the fields of specialty glass and microcrystalline glass. Accumulated over 130 years of R&D, materials and technical expertise, and has a wide range of high-quality products and smart solutions. Short is an innovation driver in a wide range of industries, including the household appliances, medicine, electronics, optics, automotive and aviation industries. Short strives to play an important role in improving people’s quality of life and focuses on promoting innovation and sustainable development. Schott Group has production bases and sales companies in 35 countries around the world. SCHOTT AG, headquartered in Mainz, Germany, is a wholly owned by the Carl Zeiss Foundation. As a company affiliated with the Foundation, Short has special responsibilities to its employees, society as a whole, and the environment. The Short Group owns a number of companies in China, including the Short (Shanghai) Precision Materials and Equipment International Trading Co., Ltd., the Short Glass Technology (Suzhou) Co., Ltd., the Short China Co., Ltd. (Hong Kong) and the joint venture company, the Short Xin Kang Pharmaceutical Packaging Co., Ltd., etc., have a total of more than 800 employees.
